#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	14132	16S	1529	1529	99.87	16S.l15.c17.ctg.1	2537	672.4	0	.	n	.	0	A69G	SNP	69	69	A	670	670	G	895	G,A,C	661,231,1	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	14132	16S	1529	1529	99.87	16S.l15.c17.ctg.1	2537	672.4	0	.	n	.	0	C1450T	SNP	1450	1450	C	2051	2051	T	887	T,C,G	881,2,4	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	14132	16S	1529	1529	99.87	16S.l15.c17.ctg.1	2537	672.4	1	SNP	n	C1184T	0	.	.	1184	1184	C	1785	1785	C	919	C	919	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	14132	16S	1529	1529	99.87	16S.l15.c17.ctg.1	2537	672.4	0	HET	.	.	.	T454TG	.	454	454	T	1055	1055	T	909	TG,T	662,227	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	23620	23S	2890	2890	99.93	23S.l15.c4.ctg.1	4209	700.3	0	.	n	.	0	G1337A	SNP	1337	1337	G	2038	2038	A	931	A,G	930,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	23620	23S	2890	2890	99.93	23S.l15.c4.ctg.1	4209	700.3	0	.	n	.	0	T1971C	SNP	1971	1971	T	2672	2672	C	894	C,T	893,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	23620	23S	2890	2890	99.93	23S.l15.c4.ctg.1	4209	700.3	1	SNP	n	A2045G	0	.	.	2045	2045	A	2746	2746	A	848	A	848	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	23620	23S	2890	2890	99.93	23S.l15.c4.ctg.1	4209	700.3	1	SNP	n	C2597T	0	.	.	2597	2597	C	3298	3298	C	827	C,G,T	825,1,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_U_01433c	folP.WHO_U_01433c	1	1	539	2134	folP	852	852	99.88	folP.l15.c4.ctg.1	2026	131.5	0	.	p	.	0	E151K	NONSYN	451	453	GAA	960	962	AAA	188;189;188	A;A;A	188;189;188	.	.
folP.WHO_U_01433c	folP.WHO_U_01433c	1	1	539	2134	folP	852	852	99.88	folP.l15.c4.ctg.1	2026	131.5	1	SNP	p	R228S	1	.	.	682	684	AGC	1191	1193	AGC	222;218;218	A;G;C,G	222;218;217,1	folP.WHO_U_01433c:1:1:R228S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	4520	gyrA	2751	2751	100.0	gyrA.l15.c17.ctg.1	3895	144.8	1	SNP	p	S91F	0	.	.	271	273	TCC	827	829	TCC	163;163;160	T,C,A;C;C	161,1,1;163;160	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	4520	gyrA	2751	2751	100.0	gyrA.l15.c17.ctg.1	3895	144.8	1	SNP	p	D95N	0	.	.	283	285	GAC	839	841	GAC	159;157;157	G;A;C	159;157;157	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	4520	gyrA	2751	2751	100.0	gyrA.l15.c17.ctg.1	3895	144.8	1	SNP	p	D95G	0	.	.	283	285	GAC	839	841	GAC	159;157;157	G;A;C	159;157;157	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_V_01454	mtrR.WHO_V_01454	1	1	27	1794	mtrR	633	633	100.0	mtrR.l6.c17.ctg.1	1861	120.0	1	SNP	p	G45D	0	.	.	133	135	GGC	827	829	GGC	218;216;217	G;G,A;C	218;215,1;217	mtrR.WHO_V_01454:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	980	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	1519	80.5	0	.	n	.	0	A197.	DEL	197	197	A	784	784	A	179	A	179	.	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	4570	parC	2304	2304	99.91	parC.l15.c4.ctg.1	3532	161.4	1	SNP	p	D86N	0	.	.	256	258	GAC	910	912	GAC	202;203;202	G;A,T,G;C,A	202;201,1,1;201,1	parC.WHO_M_00204c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	4570	parC	2304	2304	99.91	parC.l15.c4.ctg.1	3532	161.4	1	SNP	p	S87R	0	.	.	259	261	AGT	913	915	AGT	203;210;210	A,G;G;T,G	202,1;210;209,1	parC.WHO_M_00204c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	4570	parC	2304	2304	99.91	parC.l15.c4.ctg.1	3532	161.4	1	SNP	p	S87I	0	.	.	259	261	AGT	913	915	AGT	203;210;210	A,G;G;T,G	202,1;210;209,1	parC.WHO_M_00204c:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	4570	parC	2304	2304	99.91	parC.l15.c4.ctg.1	3532	161.4	1	SNP	p	S87W	0	.	.	259	261	AGT	913	915	AGT	203;210;210	A,G;G;T,G	202,1;210;209,1	parC.WHO_M_00204c:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	4570	parC	2304	2304	99.91	parC.l15.c4.ctg.1	3532	161.4	1	SNP	p	S88P	0	.	.	262	264	TCC	916	918	TCC	210;209;212	T;C;C	210;209;212	parC.WHO_M_00204c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4056	parE	1986	1986	100.0	parE.l15.c4.ctg.1	3192	158.3	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1822	1824	GGC	244;240;238	G;G;C	244;240;238	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.9.001	penA.9.001	1	1	27	3636	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2991	151.7	1	SNP	p	A311V	0	.	.	931	933	GCA	1584	1586	GCA	193;192;191	G;C;A	192;191;190	penA.9.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	3636	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2991	151.7	1	SNP	p	I312M	0	.	.	934	936	ATC	1587	1589	ATC	191;193;195	A;T;C	190;192;195	penA.9.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	3636	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2991	151.7	1	SNP	p	V316P	0	.	.	946	948	GTG	1599	1601	GTG	208;207;203	G,A;T,C;G	207,1;205,2;202	penA.9.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	3636	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2991	151.7	1	SNP	p	V316T	0	.	.	946	948	GTG	1599	1601	GTG	208;207;203	G,A;T,C;G	207,1;205,2;202	penA.9.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	3636	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2991	151.7	1	SNP	p	T484S	0	.	.	1450	1452	ACC	2103	2105	ACC	205;204;205	A,T;C;C,G	204,1;204;204,1	penA.9.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	3636	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2991	151.7	1	SNP	p	A502P	0	.	.	1504	1506	GCG	2157	2159	GCG	192;192;193	G;C,G;G	192;191,1;193	penA.9.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	3636	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2991	151.7	1	SNP	p	A502V	0	.	.	1504	1506	GCG	2157	2159	GCG	192;192;193	G;C,G;G	192;191,1;193	penA.9.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	3636	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2991	151.7	1	SNP	p	G543S	0	.	.	1627	1629	GGC	2280	2282	GGC	173;173;174	G;G;C,T	173;173;173,1	penA.9.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	3636	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2991	151.7	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2289	2291	GGC	178;178;175	G;G,A;C	178;177,1;175	penA.9.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	3636	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2991	151.7	1	SNP	p	L552S	0	.	.	1654	1656	CTG	2307	2309	CTG	176;177;176	C;T;G	176;177;176	penA.9.001:1:1:L552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	5222	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3664	177.8	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1934	1936	CCG	186;188;187	C;C;G	186;188;187	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2228	porA	1146	1146	99.65	porA.l15.c30.ctg.1	2387	116.3	0	.	p	.	0	M83fs	FSHIFT	247	247	A	904	904	C	190	C	190	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	272	porB1a	984	287	90.38	porB1a.l6.c30.ctg.1	1274	21.2	0	.	p	.	0	H217N	NONSYN	649	651	CAT	1010	1012	AAT	10;10;10	A;A;T	10;10;10	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	272	porB1a	984	287	90.38	porB1a.l6.c30.ctg.1	1274	21.2	0	.	p	.	0	D218N	NONSYN	652	654	GAT	1013	1015	AAT	10;10;10	A;A;T	10;10;10	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	272	porB1a	984	287	90.38	porB1a.l6.c30.ctg.1	1274	21.2	0	.	p	.	0	V226A	NONSYN	676	678	GTA	1037	1039	GCA	8;8;8	G;C;A	8;8;8	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	272	porB1a	984	287	90.38	porB1a.l6.c30.ctg.1	1274	21.2	0	.	p	.	0	.	MULTIPLE	700	702	ACT	1060	1062	GTA	7;7;7	G;T;A	7;7;7	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	272	porB1a	984	287	90.38	porB1a.l6.c30.ctg.1	1274	21.2	0	.	p	.	0	S236N	NONSYN	706	708	AGC	1066	1068	AAC	7;7;7	A;A;C	7;7;7	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	272	porB1a	984	287	90.38	porB1a.l6.c30.ctg.1	1274	21.2	0	.	p	.	0	.	MULTIPLE	709	711	AAC	1070	1074	TGGCG	7;7;7;7;7	T;G;G;C;G	7;7;7;7;7	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	272	porB1a	984	287	90.38	porB1a.l6.c30.ctg.1	1274	21.2	0	.	p	.	0	D238A	NONSYN	712	714	GAT	1076	1078	GCT	7;7;7	G;C;T	7;7;7	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	272	porB1a	984	287	90.38	porB1a.l6.c30.ctg.1	1274	21.2	0	.	p	.	0	V258L	NONSYN	772	774	GTA	1136	1138	TTA	30;30;31	T;T;A	30;30;31	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	272	porB1a	984	287	90.38	porB1a.l6.c30.ctg.1	1274	21.2	0	.	p	.	0	Y273H	NONSYN	817	819	TAT	1181	1183	CAT	66;66;66	C;A;T	66;66;66	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	272	porB1a	984	287	90.38	porB1a.l6.c30.ctg.1	1274	21.2	0	.	p	.	0	D274S	NONSYN	820	822	GAT	1184	1186	AGT	66;66;66	A;G;T	66;66;66	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	272	porB1a	984	287	90.38	porB1a.l6.c30.ctg.1	1274	21.2	0	.	p	.	0	N277Y	NONSYN	829	831	AAC	1193	1195	TAC	66;66;66	T;A,C;C	66;65,1;66	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2772	porB1b	1047	1047	99.24	porB1b.l15.c30.ctg.1	1872	183.3	0	.	p	.	0	N38E	NONSYN	112	114	AAT	571	573	GAA	234;235;235	G;A,T;A	234;234,1;235	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2772	porB1b	1047	1047	99.24	porB1b.l15.c30.ctg.1	1872	183.3	0	.	p	.	0	N134D	NONSYN	400	402	AAT	859	861	GAT	229;227;225	G;A,C;T,A	229;226,1;224,1	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2772	porB1b	1047	1047	99.24	porB1b.l15.c30.ctg.1	1872	183.3	0	.	p	.	0	P175S	NONSYN	523	525	CCA	982	984	TCA	228;228;230	T,G;C;A,C	227,1;228;229,1	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2772	porB1b	1047	1047	99.24	porB1b.l15.c30.ctg.1	1872	183.3	0	.	p	.	0	A218V	NONSYN	652	654	GCC	1111	1113	GTC	212;212;212	G;TCCCC,TCCC;C	212;203,1;212	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2772	porB1b	1047	1047	99.24	porB1b.l15.c30.ctg.1	1872	183.3	0	.	p	.	0	F222S	NONSYN	664	666	TTT	1123	1125	TCT	213;217;215	T;C;T	213;217;215	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2772	porB1b	1047	1047	99.24	porB1b.l15.c30.ctg.1	1872	183.3	0	.	p	.	0	E328A	NONSYN	982	984	GAA	1441	1443	GCA	243;244;243	G;C;A	243;244;243	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2772	porB1b	1047	1047	99.24	porB1b.l15.c30.ctg.1	1872	183.3	1	SNP	p	G120K	1	.	.	358	360	AAG	817	819	AAG	228;230;231	A,G;A,T,G,C;G,C	226,2;227,1,1,1;230,1	porB1b.WHO_V_02265c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2772	porB1b	1047	1047	99.24	porB1b.l15.c30.ctg.1	1872	183.3	1	SNP	p	D121N	0	.	.	361	363	GAC	820	822	GAC	232;233;235	G,A;A,C;C	231,1;232,1;235	porB1b.WHO_V_02265c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2772	porB1b	1047	1047	99.24	porB1b.l15.c30.ctg.1	1872	183.3	1	SNP	p	A121D	1	.	.	361	363	GAC	820	822	GAC	232;233;235	G,A;A,C;C	231,1;232,1;235	porB1b.WHO_V_02265c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_F_02153c	rpoB.WHO_F_02153c	1	1	539	9360	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	5341	218.6	1	SNP	p	H553N	1	H553N	NONSYN	1657	1659	CAT	2249	2251	AAT	289;286;280	A,C;A;T,A	287,1;286;279,1	rpoB.WHO_F_02153c:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1320	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1487	110.6	1	SNP	p	V57M	1	.	.	169	171	ATG	758	760	ATG	220;221;220	A;T;G,A	220;221;219,1	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
